Breakthrough to Make Bones Stronger Has The Potential to Reverse Osteoporosis
AI Image

Breakthrough to Make Bones Stronger Has The Potential to Reverse Osteoporosis

ScienceAlert • • health

Key Points:

  • A first-in-human clinical trial in Spain demonstrated that engineered mesenchymal stem/stromal cells (MSCs) with a bone marrow "return address" significantly reduced fragility fractures by 94% over two years in women over 50 with advanced osteoporosis.
  • The trial showed a decrease in fractures from an average of eight per year before treatment to 0.5 per year afterward, along with a 70% increase in bone tissue area and sustained elevation of bone formation markers for six months.
  • Participants also reported a 34% reduction in bone pain and a 30% decrease in disability two years post-infusion, suggesting potential reversal of some osteoporosis symptoms rather than just slowing progression.
  • Despite promising results, the study lacked a control group and did not track the infused MSCs to confirm their presence in bone, leaving some uncertainty about the exact mechanism behind the improvements.
  • A follow-up randomized trial with a larger cohort is underway to compare engineered autologous MSCs, donor MSCs, and no MSC treatment, aiming to validate the efficacy and mechanism of this novel therapy.

Trending Business

Trending Technology

Trending Health